Literature DB >> 24132603

Vectored expression of the broadly neutralizing antibody FI6 in mouse airway provides partial protection against a new avian influenza A virus, H7N9.

Maria P Limberis1, Trina Racine, Darwyn Kobasa, Yan Li, George F Gao, Gary Kobinger, James M Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24132603      PMCID： PMC3889513          DOI： 10.1128/CVI.00545-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


× No keyword cloud information.
  6 in total

1.  Biological features of novel avian influenza A (H7N9) virus.

Authors:  Jianfang Zhou; Dayan Wang; Rongbao Gao; Baihui Zhao; Jingdong Song; Xian Qi; Yanjun Zhang; Yonglin Shi; Lei Yang; Wenfei Zhu; Tian Bai; Kun Qin; Yu Lan; Shumei Zou; Junfeng Guo; Jie Dong; Libo Dong; Ye Zhang; Hejiang Wei; Xiaodan Li; Jian Lu; Liqi Liu; Xiang Zhao; Xiyan Li; Weijuan Huang; Leying Wen; Hong Bo; Li Xin; Yongkun Chen; Cuilin Xu; Yuquan Pei; Yue Yang; Xiaodong Zhang; Shiwen Wang; Zijian Feng; Jun Han; Weizhong Yang; George F Gao; Guizhen Wu; Dexin Li; Yu Wang; Yuelong Shu
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

2.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

3.  Epidemiology of human infections with avian influenza A(H7N9) virus in China.

Authors:  Qun Li; Lei Zhou; Minghao Zhou; Zhiping Chen; Furong Li; Huanyu Wu; Nijuan Xiang; Enfu Chen; Fenyang Tang; Dayan Wang; Ling Meng; Zhiheng Hong; Wenxiao Tu; Yang Cao; Leilei Li; Fan Ding; Bo Liu; Mei Wang; Rongheng Xie; Rongbao Gao; Xiaodan Li; Tian Bai; Shumei Zou; Jun He; Jiayu Hu; Yangting Xu; Chengliang Chai; Shiwen Wang; Yongjun Gao; Lianmei Jin; Yanping Zhang; Huiming Luo; Hongjie Yu; Jianfeng He; Qi Li; Xianjun Wang; Lidong Gao; Xinghuo Pang; Guohua Liu; Yansheng Yan; Hui Yuan; Yuelong Shu; Weizhong Yang; Yu Wang; Fan Wu; Timothy M Uyeki; Zijian Feng
Journal:  N Engl J Med       Date:  2013-04-24       Impact factor: 91.245

4.  H7N9 influenza viruses are transmissible in ferrets by respiratory droplet.

Authors:  Qianyi Zhang; Jianzhong Shi; Guohua Deng; Jing Guo; Xianying Zeng; Xijun He; Huihui Kong; Chunyang Gu; Xuyong Li; Jinxiong Liu; Guojun Wang; Yan Chen; Liling Liu; Libin Liang; Yuanyuan Li; Jun Fan; Jinliang Wang; Wenhui Li; Lizheng Guan; Qimeng Li; Huanliang Yang; Pucheng Chen; Li Jiang; Yuntao Guan; Xiaoguang Xin; Yongping Jiang; Guobin Tian; Xiurong Wang; Chuanling Qiao; Chengjun Li; Zhigao Bu; Hualan Chen
Journal:  Science       Date:  2013-07-18       Impact factor: 47.728

5.  Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza.

Authors:  Maria P Limberis; Virginie S Adam; Gary Wong; Jason Gren; Darwyn Kobasa; Ted M Ross; Gary P Kobinger; Anna Tretiakova; James M Wilson
Journal:  Sci Transl Med       Date:  2013-05-29       Impact factor: 17.956

6.  Human infection with a novel avian-origin influenza A (H7N9) virus.

Authors:  Rongbao Gao; Bin Cao; Yunwen Hu; Zijian Feng; Dayan Wang; Wanfu Hu; Jian Chen; Zhijun Jie; Haibo Qiu; Ke Xu; Xuewei Xu; Hongzhou Lu; Wenfei Zhu; Zhancheng Gao; Nijuan Xiang; Yinzhong Shen; Zebao He; Yong Gu; Zhiyong Zhang; Yi Yang; Xiang Zhao; Lei Zhou; Xiaodan Li; Shumei Zou; Ye Zhang; Xiyan Li; Lei Yang; Junfeng Guo; Jie Dong; Qun Li; Libo Dong; Yun Zhu; Tian Bai; Shiwen Wang; Pei Hao; Weizhong Yang; Yanping Zhang; Jun Han; Hongjie Yu; Dexin Li; George F Gao; Guizhen Wu; Yu Wang; Zhenghong Yuan; Yuelong Shu
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245
  6 in total
  10 in total

1.  Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice.

Authors:  Laura P van Lieshout; Geoff Soule; Debra Sorensen; Kathy L Frost; Shihua He; Kevin Tierney; David Safronetz; Stephanie A Booth; Gary P Kobinger; Xiangguo Qiu; Sarah K Wootton
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

2.  Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus.

Authors:  Virginie S Adam; Marco Crosariol; Sachin Kumar; Moyar Q Ge; Sarah E Czack; Soumitra Roy; Angela Haczku; Anna Tretiakova; James M Wilson; Maria P Limberis
Journal:  Clin Vaccine Immunol       Date:  2014-09-10

3.  In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections.

Authors:  Chasity D Andrews; Yang Luo; Ming Sun; Jian Yu; Arthur J Goff; Pamela J Glass; Neal N Padte; Yaoxing Huang; David D Ho
Journal:  Mol Ther Methods Clin Dev       Date:  2017-09-20       Impact factor: 6.698

4.  Adeno-associated virus-vectored influenza vaccine elicits neutralizing and Fcγ receptor-activating antibodies.

Authors:  Daniel E Demminger; Lisa Walz; Kristina Dietert; Helen Hoffmann; Oliver Planz; Achim D Gruber; Veronika von Messling; Thorsten Wolff
Journal:  EMBO Mol Med       Date:  2020-03-12       Impact factor: 12.137

5.  Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection.

Authors:  Yue Du; Kamran M Miah; Omar Habib; Helena Meyer-Berg; Catriona C Conway; Mariana A Viegas; Rebecca Dean; Dwiantari Satyapertiwi; Jincun Zhao; Yanqun Wang; Nigel J Temperton; Toby P E Gamlen; Deborah R Gill; Stephen C Hyde
Journal:  Thorax       Date:  2022-02-14       Impact factor: 9.139

Review 6.  Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?

Authors:  Wei Zhan; Manish Muhuri; Phillip W L Tai; Guangping Gao
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

7.  Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.

Authors:  Seleeke Flingai; Emily M Plummer; Ami Patel; Sujan Shresta; Janess M Mendoza; Kate E Broderick; Niranjan Y Sardesai; Kar Muthumani; David B Weiner
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

8.  Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle.

Authors:  Nicole K Paulk; Katja Pekrun; Gregory W Charville; Katie Maguire-Nguyen; Michael N Wosczyna; Jianpeng Xu; Yue Zhang; Leszek Lisowski; Bryan Yoo; Jose G Vilches-Moure; Gordon K Lee; Joseph B Shrager; Thomas A Rando; Mark A Kay
Journal:  Mol Ther Methods Clin Dev       Date:  2018-07-24       Impact factor: 5.849

Review 9.  In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies.

Authors:  Ami Patel; Mamadou A Bah; David B Weiner
Journal:  BioDrugs       Date:  2020-06       Impact factor: 5.807

10.  Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity.

Authors:  Joanne Marie M Del Rosario; Matthew Smith; Kam Zaki; Paul Risley; Nigel Temperton; Othmar G Engelhardt; Mary Collins; Yasuhiro Takeuchi; Simon E Hufton
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.